1.In Vivo Distribution and Therapeutic Efficacy of Magnetic Liposomes Containing Paclitaxel for Lung Cancer in Nude Mice
China Pharmacy 2007;0(30):-
OBJECTIVE:To investigate the distribution of magnetic nanoparticle embedding Paclitaxel in vivo and its curative effect on lung cancer in mice model.METHODS:The magnetic lipsomes containing Paclitaxel and the Paclitaxel liposomes were injected into caudal vein of mice,and which were exposed to magnetic field of 0.5T.The concentrations of the two drugs in different organs were determined.The lung cancer model was established in mice and the therapeutic efficacy of the different drugs on tumor was evaluated by comparing the weight of mice before and after administration.RESULTS: In the mice treated with magnetic liposome containing Paclitaxel,the drug concentration in lung which was exposed to magnetic field was significantly higher than that in the others sites,and a steady state concentration was reached quickly in lung after administration,but gradually in other organs.In the mice treated with liposomes containing paclitaxel,a steady state concentration was reached gradually in lung.The tumor control rate was 27.53% in mice treated with magnetic liposome containing Paclitaxel plus magnetic field intervention,significantly higher than in the control group.CONCLUSION: The result shows that magnetic targeting drug delivery is an effective drug delivery system,by which,the drugs can aggregate to the target site in large quantity which may lead to a reduced distribution of drugs in non-target sites.
2.Establishment and Application of "Information System for the Introduction and Examination and Approval of New Drugs" in Our Hospital
China Pharmacy 2005;0(13):-
OBJECTIVE: To strengthen the management on procedures for the introduction,examination and approval of new drugs in hospital.METHODS: The experience on the current procedures for the introduction,examination and approval of new drugs in our hospital was summarized,and the Microsoft.NET technology was used to develop Web-based "information system of introduction,examination and approval of new drugs".RESULTS & CONCLUSIONS: The new system adopted three-level "browser / server" structural pattern and it is composed of external network new drug data collection system and internal network new drug examination and approval system.The system is advanced,stabile,practical,intelligent and safe,and it has simplified the new drug examination and approval procedure,enhanced the working efficiency.Its application is characterized by justice,publicity and transparency.
3.Deguelin down-regulates the expression of cyclin D1 gene in zebrafish embroys through the whole mount in situ hybridization
Chinese Journal of Tissue Engineering Research 2015;(15):2382-2386
BACKGROUND:In the early development of zebrafish embryos, cels divide and proliferate rapidly, but low concentration of deguelin can delay the development of zebrafish embryos.
OBJECTIVE:To observe the effect of different concentrations of deguelin on cyclin D1 gene expression in zebrafish embryos.
METHODS:Though normal fertilization, zebrafish embryos that incubated to the 2-cel stage (about 0.75 hour after fertilization) and shield stage (6 hours after fertilization) were colected and put into 12-wel plates treated with 100, 200, 400 nmol/L deguelin at 28.5℃in an incubator til the shield period and 24 hours after fertilization, respectively. Simultaneously embroys treated with 1% dimethyl sulfoxide solution were as a control group, cultured in the same conditions. Cyclin D1 RNA probes were prepared for the whole mountin situhybridization, observing staining by an upright fluorescent microscope camera to detect the effect of deguelin on cyclin D1 expression in zebrafish embryos.
RESULTS AND CONCLUSION:Deguelin showed significant negative regulation on the expression of cyclin D1 gene in zebrafish embryos. Cyclin D1 expressed in outsourcing cels in embryos of shield stage, and a significant reduction in the expression of cyclin D1 came up with the increasing concentrations of deguelin. In the 400 nmol/L deguelin treatment group, there was nearly no expression of cyclin D1. Cyclin D1 expressed in the brain, central nervous system, immature eye, somites, trunk, and tail of embryos at 24 hours after fertilization, and reduced significantly in the 100 nmol/L deguelin treatment group, especialy in the proliferative area. In the 200 and 400 nmol/L treatment groups, the embryonic development slowed down signficantly, and cyclin D1 gene mainly expressed in the dorsal ectoderm cels.
4.Deguelin treatment delays embryonic development of zebrafish:A gene chip analysis
Wenhao LI ; Ruijin LIU ; Xinrong WU
Chinese Journal of Tissue Engineering Research 2013;(37):6607-6612
BACKGROUND:Anticancer drug deguelin delays the embryonic development of zebrafish, but its exact mechanism is not yet clear.
OBJECTIVE:To explore expression differences in genes and signaling pathways in deguelin-treated zebrafish embryos.
METHODS:Zebrafish embryos were harvested from zebrafish fed according to the Zebrafish Book. Zebrafish embryos at 2-cel stage were selected and divided into two groups:control group treated with dimethyl sulfoxide incubator liquid, and experimental group treated with 0.6μmol/L deguelin. Total RNA was extracted from the two groups at sphere stage. Then, gene chip technique was used to detect differential y expressed genes in the deguelin-treated zebrafish embryos. Real-time quantitative PCR was employed to validate microarray cluster analysis and pathway analysis to explore the mechanism of action of deguelin.
RESULTS AND CONCLUSION:Chip results showed that 407 genes were upregulated more than three times and 461 genes were downregulated more than three times after deguelin treatment. PCR validation results were consistent with those of the chip. Fourteen pathways were identified by KEGG pathway analysis. Deguelin may play an important role by intervening cel metabolism growth and differentiation.
5.Protective Measures Against Occupational Hazardous Factors for Pharmacists in Hospital Pharmacy
Haiying PENG ; Xinrong WU ; Xiaomin YANG
China Pharmacy 2001;0(07):-
OBJECTIVE: To analyze the occupational hazardous factors in hospital pharmacy so as to enhance pharmacist’s awareness of self-protection against such hazards. METHODS: The occupational hazardous factors including physical factors, chemical factors and psychological factors etc were analyzed and the countermeasures were discussed. RESULTS & CONCLUSIONS: Pharmacists should be cautious to the occupational hazards, strengthen traning and education, raise awareness of self-protection to guard against the occupational hazard event.
6.Importance and Model for Hospital's Evaluation on Drug Suppliers
Haiying PENG ; Lihui HU ; Xinrong WU
China Pharmacy 2007;0(34):-
OBJECTIVE:To provide references for the evaluation of drug suppliers in hospital so as to promote the suppliers to enhance their service level. METHODS: The drug suppliers were evaluated comprehensively with on-time delivery percentage, drug price and post-sale service as evaluation criteria. RESULTS & CONCLUSIONS: The evaluation of drug suppliers can not only raise the service level of the suppliers, but also facilitate a scientific and standardized management of drug supply. However, great importance should be attached to the impartiality and fairness in the evaluation.
7.Design of Individualized Dosage Regimen of Multiple Oral Dosing Theophtlline Based on Excel Function
Jin YUAN ; Xinrong WU ; Jinhui PU
China Pharmacy 2007;0(26):-
OBJECTIVE:To establish a simple individualized dosage regimen of multiple oral dosing of Theophyllin. METHODS:Based on pharmacokinetic parameters,Excel function was used to design the dosage regimen of multiple oral dosing extravascular administration of one-compartment model with Theophylline as an example. RESULTS:The following parameters such as plasma drug concentration at any time (t) since administration of Theophylline,peak time,maximum steady plasma-drug concentration,minimum steady plasma-drug concentration,accumulation coefficient,fluctuation percentage,fluctuation amplitude,and dosage for children and the old could be obtained and the concentration-time curves were able to be drawn from the input data including physical and pathological parameters,dosage (X0) of Theophylline,interval ?,absorption rate constant (Ka),drug clearance rate (CL),absorption fraction (F) and apparent volume of distribution (Vd). CONCLUSION:The method adopted in our study is simple,reliable and intuitive,and it is applicable for the design of the individualized dosage regimen of Theophyllin.
8.Determination of sildenafil citrate content by capillary zone electrophoresis
Xinrong ZHANG ; Yifeng CHAI ; Xiangfeng WU ; Lili LIU ; Genjin YANG
Academic Journal of Second Military Medical University 2001;22(5):427-428
Objective: To establish capillary zone electrophoresis method for determination of sildenafil citrate (Viagra) content in its troche. Methods: Using tetrandrine as internal standard(IS), the electrophoretic separation was achieved with 25 mmol/L borate (pH=7.89) running buffer. And a voltage of 14 kV was applied to the 40 cm×75 μm(i.d) capillary. The analytes were introduced into capillary by siphon (1 s) and determined with on-column monitoring at 214 nm. Results:The determination could be completed within 4 min and the minimum concentration of detection was 5 μg/ml.The analytical results of sildenafil citrate samples demonstrated a good linear relationship within the range of 24-480 μg/ml.The relative standard deviations (RSD) of intra-day was less than 1.58% and that of inter-day was less than 2.46%.The present recoveries were between 95%-105%. Conclusion:The CZE method is accurate, simple, rapid and reliable, so it can be applied to the determination of sildenafil citrate content.
9.Establishment and Application of Control Model of Hospital Drug Stock
Xianwen LI ; Lei SHI ; Xinrong WU ; Shujin ZHAO
China Pharmacy 2001;0(09):-
OBJECTIVE:To study the control model of hospital drug stock.METHODS:We established the control model of hospital drug stock named as"ABC rule of periodical and quantitative drug management"by combining the rule of ABC classified drug management,quantitative order drug management,and periodical order drug management.RESULTS&CON?CLUSION:The drug stock was controlled reasonably by using this control model.That ensured drug neither overstocked nor run out of,the drug stock kept within the amount of sale in20days in drug storehouse,and in25days in pharmacy.
10.Biological characterization and in vitro biocompatibility of human placenta derived mesenchymal stem cells
Jia WU ; Yongmei WEN ; Xinrong LV ; Yandong MU
Chinese Journal of Tissue Engineering Research 2017;38(5):755-759
BACKGROUND:At present bone marrow mesenchymal stem cel s act as the main seed cel s in bone tissue engineering, but only 0.001%-0.01%cel s are in the bone with difficulty in cel separation and purification. OBJECTIVE:To explore the biological characterization of human placenta derived mesenchymal stem cel s and biocompatibility with three-dimensional porous hydroxyapatite ceramic scaffold. METHODS:Human placenta derived mesenchymal stem cel s were morphological y observed and identified usingflow cytometry, fol owed by osteogenic, adipogenic, chondrogenic induction for 3 weeks. Afterwards, the potential of multi-directional differentiation was identified by alizarin red S, oil red O and toluidine blue staining. DAPI staining was used to observe the adhesion of cel s on the surface of the hydroxyapatite ceramic scaffold under scanning electron microscope. RESULTS AND CONCLUSION:The human placenta derived mesenchymal stem cel s showed long spindle shape and uniform size under the microscope;they highly expressed CD29 and D90, but did not express CD45 and CD106. Fol owing induction, mineralized nodules were observed by alizarin red S staining, lipid droplets by oil red O staining and blue-dyed toluidine blue staining. These cel s adhered wel to the scaffold surface, indicting they are suitable for bone tissue engineering.